FDA Drug information
Jardiance
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- JARDIANCE EMPAGLIFLOZIN 10 mg/1 A-S Medication Solutions
- JARDIANCE EMPAGLIFLOZIN 10 mg/1 A-S Medication Solutions
- Jardiance EMPAGLIFLOZIN 10 mg/1 Boehringer Ingelheim Pharmaceuticals, Inc.
- Jardiance EMPAGLIFLOZIN 10 mg/1 Boehringer Ingelheim Pharmaceuticals, Inc.
- Jardiance EMPAGLIFLOZIN 10 mg/1 Cardinal Health 107, LLC
- Jardiance EMPAGLIFLOZIN 25 mg/1 A-S Medication Solutions
- JARDIANCE EMPAGLIFLOZIN 25 mg/1 A-S Medication Solutions
- Jardiance EMPAGLIFLOZIN 25 mg/1 Boehringer Ingelheim Pharmaceuticals, Inc.
- Jardiance EMPAGLIFLOZIN 25 mg/1 Boehringer Ingelheim Pharmaceuticals, Inc.
- Jardiance EMPAGLIFLOZIN 25 mg/1 Cardinal Health 107, LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.